Med Paper
On this page
Company details
- Legal name
- MED PAPER SA
- Listing
- MDP on the Bourse de Casablanca, active · ISIN MA0000012593 (observed 2026-10-08)
- Sector
- Not classified (our classification from the stated principal activity)
- Financial year ends
- 31 December
Overview
Year ended 31 December 2025 · annual report, signed / final · source
Read with these figures
- Qualified audit opinion. FY2025: The auditor gives a qualified ('except for') opinion: apart from the matters it names, the statements are presented fairly. Details below.
- Auditor's emphasis of matter. Autres points: without qualifying further, the auditors note delays in paying some supplier debts and instalments of financing debts; management confirms they will be absorbed and do not call the bank agreements into question (p14).
Full wording and sources
Auditor's report, year to 2025-12-31: qualified opinion ('except for')
The auditor gives a qualified ('except for') opinion: apart from the matters it names, the statements are presented fairly. Figures are shown as printed; those affected by the named matters may be misstated. Fondement de l'opinion avec réserve: (1) charges re-invoiced in 2010 to a former shareholder for DH 4,3 million are disputed by it; it claims repayment of a DH 0,9 million advance and its current account of DH 2 million; the board decided in 2017 to waive the DH 4,3 million receivable, negotiations to offset it against the DH 2,9 million debt continue and both are kept in the accounts; the auditors cannot tell what will become of these amounts; (2) a March 2023 agreement with the tax administration to settle tax arrears by March 2025 was not respected; the auditors cannot tell the final outcome; (3) a CNSS (social security) settlement revised in January 2025 (debt KMAD 10 888, penalty remission KMAD 4 034 subject to monthly payments to January 2030): outcome unknown; late-payment penalties of KMAD 2 318 were capitalised as immobilisations en non-valeur, which the auditors consider should not be deferred charges; (4) a MMAD 2 debit by a bank in 2025, recorded by the company as a reduction of its debt to that bank, lacks sufficient evidence; the auditors cannot conclude on its accounting (PDF pp11-12).
Source: MED PAPER — Rapport Financier Annuel 2025, p11 (dated 2026-03-30)
Auditor's emphasis of matter
Autres points: without qualifying further, the auditors note delays in paying some supplier debts and instalments of financing debts; management confirms they will be absorbed and do not call the bank agreements into question (p14).
Source: MED PAPER — Rapport Financier Annuel 2025 (dated 2026-03-30)
-
Revenue
MAD 88.4 million
88,408,885.33 MAD units · p39
−16.3% vs 2024
-
Operating profit / (loss)
−MAD 10.4 million
(10,355,525.86) MAD units · p39
Moved from profit to loss (FY2024: 6.199.680,89 MAD units)
-
Profit / (loss) for the year
MAD 6.71 million
6,713,105.5 MAD units · p40
−15.9% vs 2024
-
Total assets
MAD 339 million
338,860,655.46 MAD units · p37
−4.1% vs 2024
-
Total equity
MAD 41.1 million
41,145,968.11 MAD units · p38
+19.5% vs 2024
-
Cash from operations
Not reported in this filing
Large amounts are rounded for reading (MAD million / billion / trillion); exact figures as printed are under each amount and in the tables. No currency conversion.
Business overview
Med Paper is a Moroccan paper manufacturer, founded in 1948 as Papelera De Tetuan. The company describes itself as making packaging paper and printing and writing paper; it says it has abandoned products made from wood pulp and now produces 100% Moroccan recycled paper on two paper machines. The filing does not break down sales by product or market, so no main product line is given. The figures are the company's own statements.
Source: Annual report 2025, p7, p28, p30, p44
Financial trends
FY2024 and FY2025, the company's own statements under Moroccan accounting standards, in Moroccan dirhams. Read with the warnings under Overview.
- Comparing FY2024 with FY2025, sales (chiffre d'affaires) fell 16.3%, from MAD 106 million to MAD 88.4 million, and the operating result moved from a profit of MAD 6.20 million to a loss of MAD 10.4 million. Management describes a difficult situation caused by the fall in sales. (Annual report 2025, p28)
- In FY2025 the current result (operating plus financial) was a loss of MAD 15.1 million, and net profit of MAD 6.71 million came from a non-current result of MAD 22.1 million, made up of other non-current income that the filing does not explain; in FY2024 the current result was a profit of MAD 2.92 million and net profit MAD 7.99 million. The auditors qualified their opinion, among other matters because MAD 2.32 million of late-payment penalties was capitalised as a deferred charge rather than expensed. (Annual report 2025, p12, p40)
- Financing debt (dettes de financement) fell from MAD 126 million at the end of FY2024 to MAD 97.8 million at the end of FY2025, while short-term bank debt (trésorerie passif) was MAD 68.4 million at the end of FY2024 and MAD 70.2 million at the end of FY2025, against cash of MAD 631,925 at the end of FY2025. The auditors note delays in paying some supplier debts and financing instalments. (Annual report 2025, p14)
The filings collected for this profile cover two annual periods, FY2024 and FY2025.
The auditors gave a qualified opinion on the FY2025 statements, covering disputed balances with a former shareholder, tax and social-security arrears, late-payment penalties capitalised instead of expensed, and a bank debit they could not verify.
The auditors note delays in paying some supplier debts and instalments of financing debts.
How the calculated figures are worked out
- Sales change FY2024 to FY2025: (Chiffres d'affaires FY2025 (annual report 2025, p39) − Chiffres d'affaires FY2024 (annual report 2025, p39)) ÷ Chiffres d'affaires FY2024 (annual report 2025, p39) × 100 = −16.3%
Calculated by us from the figures in the tables below; rounded once, at the end, to the places shown. Not part of the published statements or the CSV.
Business overview and trends written from the company's filings cited above and checked with AI assistance on 19 October 2026; not independently reviewed. Historical figures only: not investment advice, a valuation or a forecast.
Financial statements
Exact figures as printed. Each column comes from one filing; labels are as printed in the newest filing. Amounts in MAD units unless the row says otherwise; brackets are negative.
† from a supplementary filing for the same year · ‡ signed audited statements preferred over a disputed figure · “–” is a printed dash, explained below the table
Column sources
- FY2025 — annual report, signed / final; reported for the year · source
- FY2024 — annual report, signed / final; comparative in the FY2025 filing · source
Income statement
| Line (as printed) | FY2025Annual reportreported for the year | FY2024Annual reportcomparative in FY2025 filing |
|---|---|---|
| PRODUITS D'EXPLOITATION1 | 78,719,037.49 | 101,768,463.80 |
| Chiffres d'affaires | 88,408,885.33 | 105,563,865.54 |
| Variation de stocks de produits (1)2 | (9,689,847.84) | (3,795,401.74) |
| CHARGES D'EXPLOITATION3 | 89,074,563.35 | 95,568,782.91 |
| Achats consommés(2) de matières et fournitures4 | 47,288,437.74 | 52,815,142.62 |
| Autres charges externes5 | 12,900,928.94 | 12,510,812.25 |
| Impôts et taxes6 | 940,856.63 | 784,960.48 |
| Charges de personnel | 22,149,334.06 | 23,919,353.88 |
| Dotations d'exploitation7 | 5,795,005.98 | 5,538,513.68 |
| RESULTAT D'EXPLOITATION (I-II) | (10,355,525.86) | 6,199,680.89 |
| PRODUITS FINANCIERS | 6,833.75 | 43,826.02 |
| CHARGES FINANCIERES | (4,787,822.16) | (3,318,523.68) |
| RESULTAT FINANCIER (IV-V)8 | (4,780,988.41) | (3,274,697.66) |
| RESULTAT COURANT (III+VI)9 | (15,136,514.27) | 2,924,983.23 |
| PRODUITS NON COURANTS10 | 22,217,563.51 | 5,418,500.68 |
| CHARGES NON COURANTES11 | (91,359.74) | (80,757.27) |
| RESULTAT NON COURANT (VIII-IX)12 | 22,126,203.77 | 5,337,743.41 |
| RESULTAT AVANT IMPOTS (VII+X) | 6,989,689.50 | 8,262,726.64 |
| IMPOTS SUR LES RESULTATS | (276,584.00) | (277,495.00) |
| RESULTAT NET (XI-XII) | 6,713,105.50 | 7,985,231.64 |
Notes and alternative reported figures (12)
- “PRODUITS D'EXPLOITATION” is an issuer-specific line, not mapped to a shared definition: Printed total of operating income.
- “Variation de stocks de produits (1)” is an issuer-specific line, not mapped to a shared definition: Change in stocks of products (negative: a decrease).
- “CHARGES D'EXPLOITATION” is an issuer-specific line, not mapped to a shared definition: Printed total of operating charges (positive amounts).
- “Achats consommés(2) de matières et fournitures” is an issuer-specific line, not mapped to a shared definition: Raw materials and supplies consumed.
- “Autres charges externes” is an issuer-specific line, not mapped to a shared definition: Other external charges.
- “Impôts et taxes” is an issuer-specific line, not mapped to a shared definition: Taxes other than income tax.
- “Dotations d'exploitation” is an issuer-specific line, not mapped to a shared definition: Operating depreciation and provision charges.
- “RESULTAT FINANCIER (IV-V)” is an issuer-specific line, not mapped to a shared definition: Financial income less financial charges.
- “RESULTAT COURANT (III+VI)” is an issuer-specific line, not mapped to a shared definition: Operating result plus financial result.
- “PRODUITS NON COURANTS” is an issuer-specific line, not mapped to a shared definition: Printed total of non-current income.
- “CHARGES NON COURANTES” is an issuer-specific line, not mapped to a shared definition: Printed total of non-current charges.
- “RESULTAT NON COURANT (VIII-IX)” is an issuer-specific line, not mapped to a shared definition: Non-current income less non-current charges.
Balance sheet
| Line (as printed) | FY2025Annual reportreported for the year | FY2024Annual reportcomparative in FY2025 filing |
|---|---|---|
| Immobilisations en non valeurs→[A]1 | 2,130,187.73 | 86,400.03 |
| Immobilisations incorporelles→ [B] | 65,987,742.00 | 65,987,742.00 |
| Immobilisations corporelles →[C] | 94,681,624.08 | 100,201,542.54 |
| Immobilisations financières→[D]2 | 1,637,824.76 | 1,637,824.76 |
| TOTAL (A+B+C+D+E) | 164,437,378.57 | 167,913,509.33 |
| Stocks→[F] | 40,430,699.08 | 50,681,053.06 |
| Créances de l'actif circulant→[G]3 | 133,241,879.23 | 133,968,616.13 |
| Ecarts de conversion actif→ [I]|Eléments circulants4 | 118,773.92 | Not reported in this filing5 |
| TOTAL II (F+G+H+I) | 173,791,352.23 | 184,649,669.19 |
| Trésorerie-Actif | 631,924.66 | 762,389.68 |
| TOTAL GENERAL I+II+III | 338,860,655.46 | 353,325,568.20 |
| Capital social ou personnel (1) | 47,838,230.00 | 47,838,230.00 |
| Réserve légale6 | 0.46 | 0.46 |
| Report à nouveau (2) | (13,405,367.85) | (21,390,599.49) |
| Résultat net de l'exercice (2)7 | 6,713,105.50 | 7,985,231.64 |
| Total des capitaux propres (A) | 41,145,968.11 | 34,432,862.61 |
| Dettes de financement (C) | 97,830,543.27 | 125,943,411.37 |
| TOTAL I (A+B+C+D+E)8 | 138,976,511.38 | 160,376,273.98 |
| Dettes du passif circulant (F)9 | 129,502,837.45 | 124,525,806.11 |
| Autres provisions pour risques et charges (G)10 | 116,225.52 | Not reported in this filing11 |
| Ecarts de conversion - passif (Eléments circulants) (H)12 | 113,154.06 | Not reported in this filing13 |
| TOTAL II (F+G+H) | 129,732,217.03 | 124,525,806.11 |
| TRESORERIE PASSIF | 70,151,927.05 | 68,423,488.11 |
| TOTAL GENERAL I+II+III | 338,860,655.46 | 353,325,568.20 |
Notes and alternative reported figures (13)
- “Immobilisations en non valeurs→[A]” is an issuer-specific line, not mapped to a shared definition: Deferred charges (CGNC 'immobilisations en non valeurs'), net.
- “Immobilisations financières→[D]” is an issuer-specific line, not mapped to a shared definition: Financial fixed assets, net.
- “Créances de l'actif circulant→[G]” is an issuer-specific line, not mapped to a shared definition: Current receivables (trade, staff, state, other debtors, prepayments), net.
- “Ecarts de conversion actif→ [I]|Eléments circulants” is an issuer-specific line, not mapped to a shared definition: Unrealised exchange losses on current items.
- Not reported in this filing: Not printed for 2024: the line 'Ecarts de conversion actif→ [I]|Eléments circulants' carries a 2025 amount (118.773,92) only; the 2024 column is left blank (p37, checked on the page image).
- “Réserve légale” is an issuer-specific line, not mapped to a shared definition: Legal reserve.
- “Résultat net de l'exercice (2)” is an issuer-specific line, not mapped to a shared definition: The year's net result shown within equity.
- “TOTAL I (A+B+C+D+E)” is an issuer-specific line, not mapped to a shared definition: Equity, financing debts and durable provisions (CGNC financement permanent).
- “Dettes du passif circulant (F)” is an issuer-specific line, not mapped to a shared definition: Trade, staff, social, state, associates and other current payables.
- “Autres provisions pour risques et charges (G)” is an issuer-specific line, not mapped to a shared definition: Current provisions for risks and charges.
- Not reported in this filing: Not printed for 2024: the line 'Autres provisions pour risques et charges (G)' carries a 2025 amount (116.225,52) only; the 2024 column is left blank (p38, checked on the page image).
- “Ecarts de conversion - passif (Eléments circulants) (H)” is an issuer-specific line, not mapped to a shared definition: Unrealised exchange gains on current items.
- Not reported in this filing: Not printed for 2024: the line 'Ecarts de conversion - passif (Eléments circulants) (H)' carries a 2025 amount (113.154,06) only; the 2024 column is left blank (p38, checked on the page image).
Segments
Segment data not yet collected for this company in the pilot.
Dividends
Proposed or recommended, declared and paid are different events and are kept apart. A statement that no dividend was proposed does not mean none was paid.
No dividend statement or amount collected.
Sources
Each filing used on this page, newest period first. Dates are the document's own; the date we retrieved a file is shown separately and is never a publication date.
-
MED PAPER — Rapport Financier Annuel 2025
Year ended 31 December 2025 · Annual report · signed / final
Audit: ADLES Consulting (H. El Mardi); OURTASSI Audit & Conseil (L. Ourtassi), qualified opinion · signed
Auditor's sign-off: ADLES Consulting, H. El Mardi; OURTASSI Audit & Conseil, L. Ourtassi
Final status: The commissaires aux comptes' 'Rapport général' on the états de synthèse for the year ended 31 December 2025 (PDF pp10-17, image insert) gives a qualified opinion, is dated 'Tanger, le 30 Mars 2026' and is signed over stamps: ADLES Consulting (H. El Mardi, Associée) and OURTASSI Audit & Conseil (L. Ourtassi, Associée) (page image p17); pages are initialled. The management report was approved by the Conseil d'Administration on 30 March 2026 (auditors' report, p14).
- Document date
- 30 Mar 2026
- Auditor's report
- 30 Mar 2026
- Board approval
- date not found in this document
- Retrieved by us
- 8 Oct 2026 (not a publication date)
- Used for
- statement columns FY2025, FY2024
- Basis
- company statements · MAD units (printed “Not printed on the statement pages: amounts in dirhams with centimes (the auditors' report states DH 41 145 968 of equity, p11)”)
- Fondement de l'opinion avec réserve: (1) charges re-invoiced in 2010 to a former shareholder for DH 4,3 million are disputed by it; it claims repayment of a DH 0,9 million advance and its current account of DH 2 million; the board decided in 2017 to waive the DH 4,3 million receivable, negotiations to offset it against the DH 2,9 million debt continue and both are kept in the accounts; the auditors cannot tell what will become of these amounts; (2) a March 2023 agreement with the tax administration to settle tax arrears by March 2025 was not respected; the auditors cannot tell the final outcome; (3) a CNSS (social security) settlement revised in January 2025 (debt KMAD 10 888, penalty remission KMAD 4 034 subject to monthly payments to January 2030): outcome unknown; late-payment penalties of KMAD 2 318 were capitalised as immobilisations en non-valeur, which the auditors consider should not be deferred charges; (4) a MMAD 2 debit by a bank in 2025, recorded by the company as a reduction of its debt to that bank, lacks sufficient evidence; the auditors cannot conclude on its accounting (PDF pp11-12).
- CGNC statements: charges are printed as positive amounts; the compte de produits et charges splits each line between operations of the year and of prior years (2025: 2 953 761,74 of prior-year operating charges); the totals column is transcribed. The bilan actif prints gross, amortisation and net; the net columns are transcribed.
- Company (social) statements only; the document prints no consolidated statements (titres de participation 101 500,00, p37).
Technical details
- File
- 84 pages, with a text layer
- SHA-256
1c38089c7767c9d8d14d2f040bf10b7abd5ba07a97b431ff1e10c044e560e6b7- Entity as printed
- MED PAPER SA, Tanger
- Regulator copy
- retrieved 2026-10-08T18:32:49Z
Data notes
No figure-level notes beyond those in the tables.
Sources checked with AI assistance; independent review has not been completed. Every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (16 October 2026). Automated checks and the AI-assisted verification are not independent review. Methodology
Download
Figures shown on this page (CSV) — the same selected figures at their exact printed values, each with its source document, SHA-256, page, selection rule and reading. Independent review of these figures is pending.
Updates and corrections
Dated records only, newest first. Each date says what it means: when the company or exchange published a document, when our monitor first found it, when its figures were added to our data, or when a correction was applied. A correction is marked as an error in the company's report or as our own correction.
-
Summary refreshed
The business overview and financial-trend summary on this page were written from the published figures and checked against them on this date (AI-assisted verification).
-
Added to our financial data
Figures from the annual report for FY2025 added to our financial data (85 figures).